Darren M Ashcroft

Medication safety at the interface: evaluating risks associated with discharge prescriptions from mental health hospitals

D. Ashcroft, R. Keers, L. Prescott, 2015, Journal of clinical pharmacy and therapeutics.

Beyond LDL-C: unravelling the residual atherosclerotic cardiovascular disease risk landscape—focus on hypertriglyceridaemia

H. Soran, M. France, J. Schofield, 2024, Frontiers in cardiovascular medicine.

Assessing the severity of Type 2 diabetes using clinical data‐based measures: a systematic review

M. Rutter, I. Buchan, C. Chew‐Graham, 2019, Diabetic medicine : a journal of the British Diabetic Association.

Indirect effects of the COVID-19 pandemic on diagnosing, monitoring, and prescribing in people with diabetes and strategies for diabetes service recovery internationally.

K. Khunti, J. Valabhji, A. Wright, 2024, Diabetes research and clinical practice.